Fennec Pharmaceuticals schedules third-quarter 2026 results release

FENC•2026-11-06

Fennec Pharmaceuticals will release its third-quarter 2026 financial results before U.S. markets open on Nov. 12 and hold a conference call and webcast at 8:30 a.m. Eastern Time.

1. Results and call scheduled

Fennec Pharmaceuticals will release third-quarter 2026 financial results before U.S. markets open on Nov. 12, 2026. Management will host a conference call and webcast at 8:30 a.m. Eastern Time that day to discuss financial and business results.

Fennec Pharmaceuticals schedules third-quarter 2026 results release

1. Results and call scheduled

Related News

Cogent Communications Holdings: KeyBanc cuts to sector weight from overweight

Garanti BBVA launches share buyback program of up to TRY 11 billion

VisionSys AI raises USD 125 million in private placement

JOYY publishes update to financial calendar

UK telco blowup has slim path to avert Altice fate